Different Exercise Training Programs in University Students with Primary Dysmenorrhea
Launched by HASAN KALYONCU UNIVERSITY · Feb 28, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different exercise programs can help university students who experience primary dysmenorrhea, which is severe menstrual pain. The researchers want to find out which types of exercise—whether it's high-intensity workouts or gentler activities like yoga—are more effective in reducing pain, improving sleep, and enhancing quality of life for those affected by this condition.
To participate, women aged 18 to 25 who have been diagnosed with primary dysmenorrhea and experience regular menstrual cycles are eligible. Participants should have a body mass index (BMI) between 18 and 35 and have been experiencing menstrual pain rated at 4 cm or higher on a pain scale for at least the last six months. Those with certain health issues or who have taken specific medications, among other criteria, will not be eligible. If you choose to join, you'll engage in different exercise programs and help researchers understand which methods work best for managing menstrual pain. This study aims to provide valuable insights and evidence-based recommendations for treating this common issue.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Nulliparous female university students aged 18-25 years who volunteered to participate in the study, met the criteria specified in the PD Consensus Guidelines and were diagnosed with PD by a gynecologist
- • Individuals with a body mass index (BMI) between 18-35
- • Individuals with a regular menstrual cycle (28 ± 7 days)
- • Individuals with menstrual pain Visual Analog Scale (VAS) score of 4 cm or higher for the last 6 months
- Exclusion Criteria:
- • Gastrointestinal, urogynecologic, autoimmune, psychiatric, neurological diseases or other chronic pain syndromes
- • Having given birth and/or being pregnant
- • Intrauterine device users
- • Pelvic surgery patients
- • Taking oral contraceptives or medication, including antidepressants, for at least 6 months before the study
- • Those with a pathological history or ultrasonography result indicating secondary dysmenorrhea
- • Those who use alternative treatment methods and exercise regularly
- • Serious traumatic life events that occurred in the three months prior to the start of the study
- • Communication problems that may interfere with the implementation of assessments and/or treatment program
About Hasan Kalyoncu University
Hasan Kalyoncu University is a distinguished academic institution dedicated to advancing research and education in the health sciences. With a commitment to innovation and excellence, the university actively sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. By fostering collaboration among researchers, healthcare professionals, and industry partners, Hasan Kalyoncu University strives to contribute to the development of effective therapies and interventions, ultimately aiming to address pressing health challenges and promote public well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kilis, , Turkey
Kilis, Province, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported